Tagged with ERS

London Among the assorted pharma CEOs and KOLs gathered at the recent Financial Times Pharmaceutical and Biotechnology Conference in London, debate raged on the pros and cons of a pure play strategy, focusing on a few key therapeutic areas, compared to a more diversified approach. If the 1990s and early 2000s, were all…

Philippines Kuntal Baveja, country head and president of Sandoz Philippines Corporation discusses the company’s expanding portfolio in the country and how the booming generic industry over the past years has helped to expand access to affordable medications to the Filipinos, still pointing out that there is much room for expansion in…

Luxembourg The CEO of LIH, Dr Catherine Larue, reveals how LIH’s mission is to translate research knowledge into clinical applications; how since 2008, Luxembourg has made personalized healthcare a priority area, particularly for cancer patients; and why Luxembourg has all the ingredients to be considered amongst the leading life sciences countries…

Ireland Dermot O’Callaghan, cofounder and Director of Business Development, tells us the exciting story behind the genesis of Enterprise System Partners, an Irish success story providing manufacturing execution systems (MES) and serialization solutions to the pharmaceutical, biotechnology and medical devices industries. He outlines how the industry within Ireland has grown along…

Singapore Toshifumi Tada, Managing Director of MT Pharma, shares the significance of Singapore to their presence in the region, the strategic direction of the company to “open up the future,” as well as their partnership efforts with local communities. With the company recently establishing its legal entity in Singapore in April…

Mexico. B. Braun Paulina Escobedo, general manager of B. Braun Medical Mexico, provides insights into the impressive development of this division since it was set up in the country in 2011, while the company will introduce its pharma product portfolio in Mexico in the upcoming months. She also documents the comprehensive partnership approach…

Research Dr. Thomas Coffman, Dean at Duke-NUS Medical School (Duke-NUS), explains how Duke-NUS has effectively disrupted medical education since the establishment of this unique collaboration 11 years ago. Can you introduce to our international readers the underlying aspirations behind the creation of this partnership between Duke University and NUS as well…

Pharma Patricia Ostrosky, general director of the Institute of Biomedical Research in Mexico, details current research subjects and calls for greater collaboration between Mexican universities and the pharmaceutical industry to bring more life-changing innovation to patients. Could you please provide our readers with a general overview of the Institute of Biomedical…

Pharma Thilo Stadler speaks passionately about Grünenthal’s collaborative partnerships, company goals, and workforce engagement; revealing himself to be someone who truly believes in Grünenthal’s business. You currently hold the position of Regional General Manager South Europe and the Nordics and Managing Director of the Italian subsidiary. What were the main objectives…

Pharma Dr. Teresa Corona Vázquez, the general director of one of the leading neuroscience institutions in Latin America, details their most important research partnerships and achievements, notably with regards to neurodegenerative diseases, and her expectations of fostering a heightened research-based relationship with the pharmaceutical industry. What have been some of the…

Pharma Leading in some areas, lagging in others, the Italian healthcare logistics sector is on the brink of change according to UPS Healthcare’s managing director for Italy, Jaap Heukers.  Each country has slightly different interpretations of certain regulations and compliance, given their unique regulatory development path. Coming from a global international…

Pharma Matthieu Brand, who has been heading the French affiliate of World Courier, AmerisourceBergen for 2.5 years now, shares with great passion the bright future lying ahead of the company in France, their “a la carte” logistics service offering in the fields of clinical trials and R&D, as well the ambitions…